HIST1H2BB and MAGI2 methylation and somatic mutations as precision medicine biomarkers for diagnosis and prognosis of high-grade serous ovarian cancer

  • Blanca L. Valle
  • , Sebastian Rodriguez-Torres
  • , Elisabetta Kuhn
  • , Teresa Díaz-Montes
  • , Edgardo Parrilla-Castellar
  • , Fahcina P. Lawson
  • , Oluwasina Folawiyo
  • , Carmen Ili-Gangas
  • , Priscilla Brebi-Mieville
  • , James R. Eshleman
  • , James Herman
  • , Ie Ming Shih
  • , David Sidransky
  • , Rafael Guerrero-Preston*
    • *Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'HIST1H2BB and MAGI2 methylation and somatic mutations as precision medicine biomarkers for diagnosis and prognosis of high-grade serous ovarian cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology